Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.
about
Immunomodulatory Effects of Chitotriosidase EnzymeDifferent Brain Regions are Infected with Fungi in Alzheimer's Disease.Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery diseaseLongitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography.Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.Fungal Enolase, β-Tubulin, and Chitin Are Detected in Brain Tissue from Alzheimer's Disease Patients.Chitotriosidase Activity and Gene Polymorphism in Iranian Patients with Gaucher Disease and Sibling Carriers.Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disordersYKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease.Diagnostic function of the neuroinflammatory biomarker YKL-40 in Alzheimer's disease and other neurodegenerative diseases.Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing.Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development.Gut microbiome alterations in Alzheimer's disease.YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice.Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.Infection of Fungi and Bacteria in Brain Tissue From Elderly Persons and Patients With Alzheimer's Disease.Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's diseaseYKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
P2860
Q26765769-4661A5B0-9840-4C0E-8B10-726E084D3D1AQ34045152-E3B4014F-1606-4FB5-A0E9-1A36DB4A2E12Q34834538-162F8392-0294-4CD8-B7F5-3984E2479643Q36062391-2BCF674A-5172-4FCD-A510-58A606579957Q36265825-7923FDE8-866C-447F-B934-B30BA389FAB0Q36402008-12B842A0-C5C9-47E5-9E9F-1E7004800ACBQ36599172-6BBBDC56-2D8F-4AE9-8B0D-E7A11B13FA08Q37237233-95B18258-645D-4684-B523-592D90705524Q37396857-F419B5E5-790F-4AE4-93BA-F17ABE3352CEQ37400427-55ABD918-5833-4269-B617-76A8D4B36E02Q37565386-04CC499B-69D2-4E16-9848-3BB4F219D7B0Q37703133-B65739A5-10B0-4649-B731-A22FF2535BC7Q38759253-42CE5346-3D5A-4DBD-B0FE-ED9FC3D511EAQ38915171-82BAD299-D175-41F7-91D0-6D8A2A62D355Q39029436-BA293D3C-1811-4C42-8387-BDFF58EA1E6FQ40260689-6537A08B-8C78-4885-BF86-E6E54AE8280BQ42656279-7F280753-E0AE-469D-99F6-519CAE5861A4Q42670350-831794CE-19FC-49E5-8BDF-C279F8CD59C3Q45811351-67E17EA2-BA9F-4777-AF10-270F21030EC9Q47715715-25D95211-4850-4DA4-B964-27B9FD24E85AQ47855094-33DB49DC-80D3-4B7C-BBB9-87320D18933BQ50583452-238D78A5-7490-4C0C-B5DB-52F0EC13EF50Q50591921-4E2DB9B5-5AF8-4774-A60B-5BD7E1F22D75Q55017301-F1BF7E86-77EE-4EB0-B406-5105A942B4AFQ57493750-38B68044-3C70-438A-97EC-44CB8DF07745Q58742056-B9EDF8DF-8130-4FB5-BF0B-CA162B4781E7
P2860
Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@ast
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@en
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@nl
type
label
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@ast
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@en
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@nl
prefLabel
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@ast
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@en
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@nl
P2093
P2860
P356
P1476
Increased Levels of Chitotrios ...... ents with Alzheimer's Disease.
@en
P2093
Albert Lladó
Carl-Henrik Andersson
Christoffer Rosén
José L Molinuevo
Lorena Rami
Maria Bjerke
Ulf Andreasson
P2860
P304
P356
10.1159/000362164
P577
2014-05-01T00:00:00Z